REG - Creo Medical Group - Holding(s) in Company

Creo MedicalAnnouncement

13/03/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230313:nRSM6576Sa&default-theme=true

RNS Number : 6576S  Creo Medical Group PLC  13 March 2023

TR-1: Standard form for notification of major holdings

 

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible) (i)

 1a. Identity of the issuer or the underlying issuer of existing shares to                                                                                                    CREO MEDICAL GROUP PLC
 which voting rights are attached (ii):
 1b. Please indicate if the issuer is a non-UK issuer  (please mark with an
 "X" if appropriate)
 Non-UK issuer
 2. Reason for the notification (please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights                                                                                                                                                                                                                                                                                 X
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights                                                                                                                                                                                                                                                                            X
 Other (please specify) (iii):
 3. Details of person subject to the notification obligation (iv)
 Name                                                                                                                                                                         CANACCORD GENUITY GROUP INC
 City and country of registered office (if applicable)                                                                                                                        VANCOUVER, CANADA
 4. Full name of shareholder(s) (if different from 3.) (v)
 Name                                                                                                                                                                         DISCRETIONARY CLIENTS
 City and country of registered office (if applicable)                                                                                                                        As above
 5. Date on which the threshold was crossed or reached (vi):                                                                                                                  09 MARCH 2023
 6. Date on which issuer notified (DD/MM/YYYY):                                                                                                                               10 MARCH 2023
 7. Total positions of person(s) subject to the notification obligation
                                                                               % of voting rights attached to shares (total of 8. A)            % of voting rights through financial instruments            Total of both in % (8.A + 8.B)                                     Total number of voting rights held in issuer (8.A + 8.B) (vii)

(total of 8.B 1 + 8.B 2)
 Resulting situation on the date on which threshold was crossed or reached     12.8167                                                                                                                      12.8167                                                            44,972,705
 Position of previous notification (if                                         13.9990                                                                                                                      13.9990

 applicable)
                                        8. Notified details of the resulting situation on the date on which the
                                        threshold was crossed or reached (viii)
                                        A: Voting rights attached to shares
                                        Class/type of                                           Number of voting rights (ix)                                                                                                             % of voting rights

shares

                                        ISIN code (if possible)
                                                                                                                                Direct                                                       Indirect                                                                          Direct                                                               Ind

                                                                    ire
                                                                                                                                (DTR5.1)                                                      (DTR5.2.1)                                                                       (DTR5.1)                                                             ct

                                                                                                                                                                                                                                                                                                                                                    (DT
                                                                                                                                                                                                                                                                                                                                                    R5.
                                                                                                                                                                                                                                                                                                                                                    2.1
                                                                                                                                                                                                                                                                                                                                                    )
                                        GB00BZ1BLL44                                                                                                           44,972,705                                                                                                                             12.8167

                                        SUBTOTAL 8. A                                           44,972,705                                                                                                                               12.8167

                                        B 1: Financial Instruments according to DTR5.3.1R (1) (a)
                                        Type of financial instrument                            Expiration                      Exercise/                                                                             Number of voting rights that may be acquired if the instrument is               % of voting rights

date (x)
Conversion Period (xi)

                                                                                                                                                                                                                      exercised/converted.

                                                                                                                                SUBTOTAL 8. B 1

                                        B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
                                        (1) (b)
                                        Type of financial instrument                                            Expiration      Exercise/                                                    Physical or cash                                               Number of voting rights                   % of voting rights

date (x)
Conversion Period (xi)

                                                                                                                                                                                             Settlement (xii)

                                                                                                                                                                                             SUBTOTAL 8.B.2

 

 

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the

 applicable box with an "X")
 Person subject to the notification obligation is not controlled by any natural
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuer (xiii)
 Full chain of controlled undertakings through which the voting rights and/or                                                                                                                                                                           X
 the

financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entity (please add additional rows as
 necessary) (xiv)
 Name (xv)                                                 % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                                                       than the notifiable threshold
 Canaccord Genuity Group Inc.                              12.8167                                                                                                                                                 12.8167
 Canaccord Genuity Wealth Group Holdings Limited           12.8167                                                                                                                                                 12.8167
 Canaccord Genuity Wealth Group Holdings (Jersey) Limited  12.8167                                                                                                                                                 12.8167
 Canaccord Genuity Wealth Group Limited                    12.8167                                                                                                                                                 12.8167
 Punter Southall Wealth Limited                            0.0009                                                                                                                                                  0.0009
 Canaccord Genuity Wealth Limited                          0.0064                                                                                                                                                  0.0064
 Hargreave Hale Ltd                                        12.8094                                                                                                                                                 12.8094

 

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 

 11. Additional information(xvi)
 The change in the percentage of shares held is due mainly to participation in
 the placing and open offer by Creo Medical Group plc, the shares from which
 were admitted to AIM on 09/03/2023.

 

 Place of completion  BLACKPOOL, ENGLAND
 Date of completion   10 MARCH 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLEAXDFFDADEFA